What an excellent analysis !! The way you guys have gone so deep into this subject and explained the complex aspects in such an easy to understand way, is amazing ! I can see the time and efforts that would have gone in this. I wanted to check a few things that may please be considered. I am new to this forum and has an investment in Wockhardt.
- You mentioned that 90% of the 250 patients recruited in the clinicals have fully recovered and 278 more need to be tested. I assume it is in India. This looks to be super promising. Do they need to repeat these trials in US or does FDA give approval based on Indian Phase 3 trails ?
- How much may be the business potential of WCK 4873 and does the current stock price of 450 in anyway captures this potential ?
- Would it be possible to do a similar analysis on WCK 6777 as Khorakiwala has said that its opportunity is 2.8 billion.
| Subscribe To Our Free Newsletter |
